Polar Asset Management Partners Inc. Nurix Therapeutics, Inc. Transaction History
Polar Asset Management Partners Inc.
- $4.67 Billion
- Q2 2025
A detailed history of Polar Asset Management Partners Inc. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 154,400 shares of NRIX stock, worth $1.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
154,400Holding current value
$1.6 Million% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding NRIX
# of Institutions
173Shares Held
79.3MCall Options Held
126KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$70.9 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$63 Million2.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$46.4 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.95MShares$41 Million4.19% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$40.3 Million0.45% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $490M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...